|
Name |
Diaporxanthone F
|
Molecular Formula | C32H32O13 | |
IUPAC Name* |
[7-[1,5,8-trihydroxy-10a-(hydroxymethyl)-6-methyl-9-oxo-6,7-dihydro-5H-xanthen-2-yl]-1,8-dihydroxy-4a-(hydroxymethyl)-3-methyl-9-oxo-3,4-dihydro-2H-xanthen-4-yl]acetate
|
|
SMILES |
CC(=O)OC1C(C)CC(O)=C2C(=O)c3c(ccc(-c4ccc5c(c4O)C(=O)C4=C(O)CC(C)C(O)C4(CO)O5)c3O)OC21CO
|
|
InChI |
InChI=1S/C32H32O13/c1-12-8-17(36)23-27(40)21-19(44-31(23,10-33)29(12)42)6-4-15(25(21)38)16-5-7-20-22(26(16)39)28(41)24-18(37)9-13(2)30(43-14(3)35)32(24,11-34)45-20/h4-7,12-13,29-30,33-34,36-39,42H,8-11H2,1-3H3/t12-,13-,29-,30-,31+,32+/m0/s1
|
|
InChIKey |
WEVHODGOYIQNRY-CNQNSJMVSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 624.6 | ALogp: | 2.4 |
HBD: | 7 | HBA: | 13 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 220.5 | Aromatic Rings: | 6 |
Heavy Atoms: | 45 | QED Weighted: | 0.243 |
Caco-2 Permeability: | -6.065 | MDCK Permeability: | 0.00000442 |
Pgp-inhibitor: | 0.14 | Pgp-substrate: | 0.994 |
Human Intestinal Absorption (HIA): | 0.84 | 20% Bioavailability (F20%): | 0.478 |
30% Bioavailability (F30%): | 0.092 |
Blood-Brain-Barrier Penetration (BBB): | 0.005 | Plasma Protein Binding (PPB): | 92.05% |
Volume Distribution (VD): | 0.594 | Fu: | 4.27% |
CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.079 |
CYP2C19-inhibitor: | 0.008 | CYP2C19-substrate: | 0.067 |
CYP2C9-inhibitor: | 0.014 | CYP2C9-substrate: | 0.235 |
CYP2D6-inhibitor: | 0.021 | CYP2D6-substrate: | 0.151 |
CYP3A4-inhibitor: | 0.427 | CYP3A4-substrate: | 0.249 |
Clearance (CL): | 3.649 | Half-life (T1/2): | 0.044 |
hERG Blockers: | 0.03 | Human Hepatotoxicity (H-HT): | 0.945 |
Drug-inuced Liver Injury (DILI): | 0.968 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.996 | Maximum Recommended Daily Dose: | 0.051 |
Skin Sensitization: | 0.055 | Carcinogencity: | 0.025 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.004 |
Respiratory Toxicity: | 0.146 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001991 | 0.680 | D01XDL | 0.302 | ||||
ENC004764 | 0.665 | D07VLY | 0.295 | ||||
ENC005072 | 0.626 | D0C9XJ | 0.295 | ||||
ENC001973 | 0.605 | D01XWG | 0.293 | ||||
ENC005073 | 0.603 | D0T5XN | 0.277 | ||||
ENC005074 | 0.585 | D0FX2Q | 0.262 | ||||
ENC005069 | 0.561 | D0T8EH | 0.260 | ||||
ENC002870 | 0.538 | D0AZ8C | 0.250 | ||||
ENC002105 | 0.531 | D07IPB | 0.250 | ||||
ENC005885 | 0.525 | D0G3DL | 0.249 |